email: email@example.com LINE ID:h2water
氫水,氫分子、氫氣、健康氫水,水素水,負電位,ORP,抗氧化,抗自由基,氫分子醫學,氫水,Hydrogen water,氫氣、氫,台灣氫水研究中心,氫思語,孫學軍,太田成男,鹼性離子水,小分子水,能量水,電解水,富氫水,負氫水,活水,健康,養生,活力,大氫鬆,小氫鬆,氫水機,水素,水素水機,王群光,氫氧機,綠加利,活美水素水,低氘水,活性原子氫,富氫水,負氫水,每日水素,活氫水,氫氧造水機,百樂,負氫,氫博士,氫水棒,氫源,新德美,HOH,鹼性活氫水,氫美機,負氫離子水,氫氣棒,呼吸氫氣,氫氧療法,加氫水,氫水、健康氫水、水素水、負電位、ORP、抗氧化、抗自由基 、氫分子醫學、氫水、Hydrogen water、氫氣、氫、氫水、台灣氫水實驗室、台灣氫水研究中心、氫思語、孫學軍、太田成男、鹼性離子水、小分子水、能量水、電解水、富氫水、負氫水、活水、健康、養生、活力、大氫鬆、小氫鬆、氫水機、水素、水素水機、王群光、氫氧機、綠加利、活美水素水、低氘水、活性原子氫、富氫水、負氫水、每日水素、活氫水、氫氧造水機、百樂、負氫、氫博士、氫水棒、氫源、新德美、HOH、鹼性活氫水、氫美機、負氫離子
Experimental verification of protective effect of hydrogen-rich water against cisplatin-induced nephrotoxicity in rats using dynamic contrast-enhanced CT
A Kitamura, BSc 1 S Kobayashi, BSc 1 T Matsushita, BSc 1 H Fujinawa, PhD 2 and K Murase, PhD 1
1 Department of Medical Physics and Engineering, Division of Medical Technology and Science, Faculty of Health Science, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita, Osaka 565-0871, Japan 2 I’rom Pharmaceutical, Tokyo 141-0032, Japan
Correspondence: Dr Kenya Murase, Department of Medical Physics and Engineering, Division of Medical Technology and Science, Faculty of Health Science, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita, Osaka 565-0871, Japan.
Our aim was to assess the protective effect of hydrogen-rich water against cisplatin-induced nephrotoxicity in rats usingdynamic contrast-enhanced CT (DCE-CT). DCE-CT studies were performed in 30 rats (8 weeks old) on days 0, 2, 4 and 7 using multidetector row CT. The rats were divided into three groups: a control group (n = 6) with free access to standard water and without cisplatin injection, a non-treatment group (n = 12) with free access to standard water and injected with cisplatin (3.6 mg kg–1 body weight) intraperitoneally on day 0 and a treatment group (n = 12) with free access to hydrogen-rich water starting from 7 days before cisplatin injection. The contrast clearance per unit renal volume (K1) was estimated from the DCE-CT data using the Patlak model. The contrast clearance of the entire kidney (K) was obtained by multiplying K1 by the renal volume. The serum creatinine level was also measured on day 7. The K1 and K values normalised by those on day 0 in the treatment group were significantly greater than those in the non-treatment group on days 2, 4 and 7. There were no significant differences in the normalised K value between the treatment and control groupson days 2 and 7. The serum creatinine level in the treatment group was significantly lower than that in the non-treatmentgroup and was not significantly different from that in the control group. This study demonstrated that hydrogen-rich water ameliorates renal dysfunction due to cisplatin-induced nephrotoxicity in rats.